Priyanka Gupta, M.D.
Specialist in New Braunfels, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 69,608 in Specialist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
What the federal data shows
Priyanka Gupta, M.D. reported a CMS MIPS final score of 60.5/100 - below the 83.5 national average - and filed 3,365 Medicare Part D claims in 2023.
- 60.5/100
- MIPS score · -23 vs avg
- 3K
- Part D claims, 2023
- $50.4K
- industry payments (Sunshine Act)
- ≥6th
- pct among measured MIPS (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1346281839 · Specialist
NPI-10 · ENUM-LEGACY · TAX-MEGA · MIPS-LOW · RX-MID · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1346281839
- ENUM-LEGACY 2006
- TAX-MEGA 70K Specialist
- MIPS-LOW 60.5/100
- RX-MID 3,365
- BOOK-LIGHT 2,421 in Texas
- PHOTO-FINISH Virginia Dailey Graham · ±0.2
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Stacie Grossfeld…
Stacie Grossfeld
60.1 MIPS pts
- Mary Lotfi · near
Mary Lotfi
60.3 MIPS pts
- Gupta · this pro…
Gupta · this provider
60.5 MIPS pts
- Virginia Dailey …
Virginia Dailey Graham
60.7 MIPS pts
- Katharine Leppar…
Katharine Leppard
60.8 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Priyanka Gupta, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
61 ≥ 6th percentile 6% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Priyanka Gupta, M.D. sits
This provider among specialist peers
Across the 4,261 specialist providers who report both Medicare Part D prescribing and a MIPS quality score, Priyanka Gupta, M.D. writes more Part D claims than 83% of them and scores higher on MIPS quality than 19% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one specialist peer from a representative sample of 60; the gold marker is Priyanka Gupta, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Priyanka Gupta, M.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Texas
How Specialist compares to other specialties among Texas providers
Specialist ranks #42 among Texas's specialties (0.6% of in-state providers)
Each bar is a specialty's share of the Texas provider total, by primary NUCC taxonomy. The highlighted bar is Specialist; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Priyanka Gupta, M.D.'s 2023 MIPS final score plotted against the Specialist national average
- MIPS Final Score
- 60.5/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Specialist US NPIs
60.5/100 MIPS final score - 23.0 pts below the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Specialist. Quality dim: 59. Cost dim: 92.6.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1346281839 |
|---|---|
| Specialty | Specialist |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 06/08/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Priyanka Gupta, M.D.'s current license status, disciplinary history, and board certifications with the Texas Medical Board in Texas before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1346281839 is the unique 10-digit identifier CMS uses to link Gupta across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Priyanka Gupta, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$50.4K
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Priyanka Gupta, M.D.. To verify Priyanka Gupta, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 5,287
- Total Day Supply
- 154,304
- Generic Drug Cost
- $87K
- Antibiotic Claims
- 18
Patient Demographics
- Average Patient Age
- 71.3 years
- Avg HCC Risk Score
- 0.88
- Gender Split
- 70% female / 30% male
- Age Distribution
- <65: 33, 65-74: 362, 75-84: 141, 85+: 15
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Priyanka Gupta, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Montelukast Sodium
Montelukast Sodium
762 claims
- Azelastine Hcl
Azelastine Hcl
635 claims
- Fluticasone Propio…
Fluticasone Propionate
543 claims
- Trelegy Ellipta 158
Trelegy Ellipta
158 claims
- Albuterol Sulfate … 156
Albuterol Sulfate Hfa
156 claims
- Flovent Hfa 134
Flovent Hfa
134 claims
- Levocetirizine Dih… 87
Levocetirizine Dihydrochloride
87 claims
- Ipratropium Bromide 74
Ipratropium Bromide
74 claims
| Drug | Claims |
|---|---|
| Montelukast Sodium | 762 |
| Azelastine Hcl | 635 |
| Fluticasone Propionate | 543 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 158 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 156 |
| Flovent Hfa Fluticasone Propionate | 134 |
| Levocetirizine Dihydrochloride | 87 |
| Ipratropium Bromide | 74 |
| Famotidine | 72 |
| Breo Ellipta Fluticasone/Vilanterol | 68 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Specialist Overview
How Priyanka Gupta, M.D. fits within the Specialist landscape nationally.
Priyanka Gupta, M.D.'s 3,365 claims are above the specialty average of 1,474.
Nationwide Specialist peers with similar MIPS or enrollment year
Two federal-record peer sets for Gupta, both outside Texas so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (60.5 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Specialist Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Gupta.
One of 2,421 Specialist providers enrolled in Texas, 5 are shown here.
Compare Specialist nationally: see state-by-state distribution →
Frequently Asked Questions
What is Priyanka Gupta, M.D.'s specialty? ▼
How much does Priyanka Gupta, M.D. prescribe under Medicare Part D? ▼
What is Priyanka Gupta, M.D.'s Medicare quality score? ▼
Where is Priyanka Gupta, M.D. located? ▼
What is Priyanka Gupta, M.D.'s NPI number? ▼
How many Specialist providers are there in the US? ▼
What drugs does Priyanka Gupta, M.D. prescribe most often? ▼
Does Priyanka Gupta, M.D. accept Medicare? ▼
How can I verify Priyanka Gupta, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.